EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cellini, M.
Right arrow Articles by Campos, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cellini, M.
Right arrow Articles by Campos, E. C.
Experimental Biology and Medicine 231:1081-1084 (2006)
© 2006 Society for Experimental Biology and Medicine


EYE

Effects of Endothelin-1 and Flunarizine on Human Trabecular Meshwork Cell Contraction

Mauro Cellini1, Piera Versura, Eugenio Zamparini, Edlira Bendo and Emilio C. Campos

Department of Surgery and Transplant Section Ophthalmology, Alma Mater Studiorum University of Bologna, Bologna, Italy

To whom requests for reprints should be addressed at 1 Department of Surgery and Transplant—Section Ophthalmology I, University of Bologna, Via Massarenti, 9, I-40138 Bologna, Italy. E-mail: mauro.cellini{at}unibo.it

Abstract

Trabecular meshwork (TM) cells are now considered to play an active role in the aqueous outflow mechanism because they exhibit smooth muscle–like contractile properties. Endothelin-1 (ET-1), a potent vasoconstrictor peptide, has been proposed to play a role in the local regulation of aqueous outflow and intraocular pressure (IOP) control. We propose an in vitro culture model as a method for the study of ET-1–induced human TM (HTM) cell contractility and for the study of whether pre-incubation with flunarizine, a calcium-channel blocker, can inhibit the action of ET-1. Experiments were performed on semiconfluent HTM cells (primary cultures established from normotensive human donor eyes) at the second passage, with phosphate-buffered saline (PBS) as a control. The contractile status of the cells was evaluated by a morphometric analysis of cell area, assuming that HTM cells in culture are able to reduce their area as a consequence of cytoskeletal contraction, rather than regulatory volume decrease. After incubation with 10 µM ET-1 for 5 mins, we observed a reduction of HTM cell area with respect to PBS-treated cells: 2425 ± 876 µm2 versus 3125 ± 987 µm2 (P < 0.001); and cells exhibited a retraction in shape and a reduction in number of indented profiles. Administration of ET-1 at progressively lower doses produced a corresponding lower reduction of HTM cell area, suggesting a dose-response effect of ET-1. Pre-incubation with 10 µM flunarizine strongly inhibited the ET-1 effect on HTM cell contraction: 2806 ± 865 µm2 versus 2910 ± 846 µm2 (P = not significant). Our data indicate that ET-1 induced a statistically significant reduction in the area of HTM cells versus controls, and that ET-1 can directly influence the aqueous outflow. Moreover, we observed that flunarizine inhibited the effect of ET-1 on the HTM cells.

Key Words: HTM cells • morphometric analysis • endothelin-1 • calcium channel blockers • flunarizine • cell contraction







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.